Multi-Marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET)

This study has been terminated.
(Change in company strategy)
Sponsor:
Information provided by:
Biosite
ClinicalTrials.gov Identifier:
NCT00472628
First received: May 10, 2007
Last updated: May 5, 2008
Last verified: May 2008
  Purpose

The purpose of the study is to procure blood samples from patients ≥18 years of age who present to the Emergency Department (ED) with at least two of the diagnostic criteria for sepsis. Samples obtained upon enrollment will be used for future testing of the Triage Sepsis Panel and other biomarkers.


Condition Intervention
Sepsis
Procedure: Blood samples collected

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Multi-Marker Index for the Risk Assessment of Sepsis in the Emergency Department

Resource links provided by NLM:


Further study details as provided by Biosite:

Enrollment: 0
Study Start Date: May 2007
Study Completion Date: August 2007
Detailed Description:

This is a multi-center, prospective specimen procurement study. The samples will be used for future testing of the Triage Sepsis Panel in conjunction with other laboratory tests and clinical assessments as an aid in the assessment for risk of sepsis progression within 72 hours of patients presenting in the Emergency Department and meeting the diagnostic criteria for sepsis who might be considered for hospital admission, including to the ICU. Approximately 700 patients presenting to the Emergency Department (ED) with at least two of the symptoms or signs of sepsis will be enrolled in this study.

The day of enrollment is defined as Study Day 0. Enrolled patients who are discharged to home will be contacted by telephone on Study Days 3, 14 and 28 to assess their clinical status.

Patients who are admitted to the hospital following initial enrollment will undergo the following assessments at 24, 48 and 72 hours after enrollment and at discharge (if in the hospital and alive at these time points).

Each patient will also be contacted on Study Day 14 and on or after Study Day 28 to assess the duration of hospital stay and mortality through Days 14 and 28.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Study Population

None.

Criteria

Inclusion Criteria:

  • Male or female 18 years of age or older
  • Presenting to the emergency department (ED) for evaluation and who can be enrolled within 6 hours of initial ED evaluation
  • Exhibiting two or more of any diagnostic criteria for sepsis
  • Willing and able to comply with study procedures, including follow-up telephone contact (or in-house assessment) on Study Days 3, 14, and 28

Exclusion Criteria:

  • Age < 18 years
  • Participation in any interventional clinical study within the previous 30 days
  • Status-post cardiac arrest (within the past month)
  • Moribund or with active "Do Not Resuscitate" or "Comfort Care Only" status
  • Prisoners or other institutionalized or vulnerable individuals
  • Already a hospital in-patient
  • Unwilling or unlikely to comply with study procedures or to be reachable by telephone (or in person) for Day 3, 14, and 28 status assessments if discharged
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472628

  Show 24 Study Locations
Sponsors and Collaborators
Biosite
Investigators
Principal Investigator: Emanuel Rivers, MD, MPH Henry Ford Hospital
Principal Investigator: Mitchell Levy, MD Rhode Island Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472628     History of Changes
Other Study ID Numbers: BSTE-0501 - CLOSED, Study Closed 9/13/07
Study First Received: May 10, 2007
Last Updated: May 5, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Emergencies
Sepsis
Toxemia
Disease Attributes
Pathologic Processes
Infection
Systemic Inflammatory Response Syndrome
Inflammation

ClinicalTrials.gov processed this record on July 22, 2014